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Abstract
Amyloid beta containing plaques are surrounded by dystrophic neurites in the Alzheimer disease
(AD) brain, but whether and how plaques induce these neuritic abnormalities remain unknown. We
tested the hypothesis that soluble oligomeric assemblies of Aβ, which surround plaques, induce
calcium mediated secondary cascades that lead to dystrophic changes in local neurites. We show that
soluble Aβ oligomers lead to activation of the calcium-dependent phosphatase CaN (PP2B) which
in turn activates the transcriptional factor nuclear factor of activated T cells (NFAT). Activation of
these signaling pathways, even in the absence of Aβ, is sufficient to produce a virtual phenocopy of
Aβ induced dystrophic neurites, dendritic simplification, and dendritic spine loss in both neurons in
culture and in the adult mouse brain. Importantly, the morphological deficits in the vicinity of Aβ
deposits in a mouse model of AD are ameliorated by CaN inhibition, supporting the hypothesis that
CaN/NFAT are aberrantly activated by Aβ, and that CaN/NFAT activation is responsible for
disruption of neuronal structure near plaques. In accord with this, we also detect increased levels of
an active form of CaN and NFATc4 in the nuclear fraction from the cortex of patients with AD. Thus,
Aβ appears to mediate the neurodegeneration of AD, at least in part, by activation of CaN and
subsequent NFAT-mediated downstream cascades.
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Introduction
Aβ peptide, the major component of senile plaques, accumulates in the brain of AD patients
(Walsh and Selkoe, 2004; Yaari and Corey-Bloom, 2007). The amyloid hypothesis (Hardy and
Allsop, 1991; Hardy and Selkoe, 2002) suggests that Aβ induces neurodegeneration, but the
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key molecular mechanisms that link Aβ to neuronal damage remain a critical gap in
understanding AD and designing effective therapeutics. Exposure of neurons to synthetic or
naturally secreted Aβ peptides induces a reduction of dendritic spines and synaptic dysfunction
in culture, and causes memory deficits in learned behavior in normal rats (Pike et al., 1993;
Lorenzo and Yankner, 1994; Geula et al., 1998; Shankar et al., 2007; Shankar et al., 2008). In
vivo studies using longitudinal multiphoton microscopy reveal a direct toxic effect on neurites
surrounding Aβ deposits, including dendritic simplification, loss of dendritic spines, and
neuritic dystrophies (Spires et al., 2005; Meyer-Luehmann et al., 2008). However, the
connection between extracellular Aβ and the intracellular signaling pathways that cause local
disruption of neuronal processes, synaptic dysfunction, and neurodegeneration are unknown.
Elevated intracellular calcium has been observed in neurons exposed to Aβ in several model
systems and disrupted calcium homeostasis has been suggested to play a central role in AD
pathogenesis (Palotas et al., 2002; Mattson, 2004; Smith et al., 2005; Stutzmann, 2005;
Bezprozvanny and Mattson, 2008; Busche et al., 2008). For example, we have recently
demonstrated that neurites in APP overexpressing transgenic mice have significantly elevated
intracellular calcium ([Ca2+]i) compared to age-matched nontransgenic controls (Kuchibhotla
et al., 2008).
In neurons, Ca2+ signaling is tightly controlled to ensure proper functioning of numerous
Ca2+-dependent events including processes influenced by the serine/threonine phosphatase
CaN (Mulkey et al., 1994; Wang and Kelly, 1996; Halpain et al., 1998; Berridge et al., 2000).
CaN is the only Ca2+-activated protein phosphatase in neurons and it is involved in many facets
of neuronal physiology, including synaptic plasticity, and learning and memory (Klee et al.,
1979; Winder and Sweatt, 2001). In mice, both genetic and pharmacological upregulation of
the expression of CaN can induce synaptic dysfunction and memory impairment, while CaN
inhibition strengthens memory in spatial learning tasks (Malleret et al., 2001; Winder and
Sweatt, 2001; Mansuy, 2003). We explored the possibility that AD-related neuritic
degeneration may involve altered CaN activity as a result of Ca2+ dyshomeostasis.
In the present study, we establish an in vitro model of Aβ-induced neuritic damage. Using this
model, we established molecular links between exposure to extracellular Aβ and the
morphological changes that occur in neurites around plaques. We find that soluble Aβ from
Tg2576 conditioned medium (CM) induces CaN activation and subsequent NFATc4 nuclear
translocation, which leads to dendritic spine loss, dendritic simplification, and neuritic
dystrophies. Blocking Aβ, CaN activation, or importantly, NFAT activation is each sufficient
to prevent Aβ-induced morphological alterations. Moreover, plaque-associated
neurodegenerative changes in an APP overexpressing mouse model of AD can be blocked by
inhibiting CaN. These data suggest that CaN activation and subsequent activation of NFAT-
mediated transcriptional cascades are critically involved in Aβ-induced neurotoxicity,
providing mechanistic insight into the “black box” between Aβ and synaptic failure.
Materials and Methods
Primary Neuronal Cultures
The animals utilized for generating cell cultures were transgenic mice expressing human APP
(Tg2576 line: transgenic mice overexpressing the 695-amino acid isoform of human Alzheimer
β-amyloid precursor protein containing the double Swedish mutation K670N, M671L with a
hamster prion protein gene promoter in B6;SJL F2 mice) (Hsiao et al., 1996). Primary neuronal
cultures were derived from cerebral cortex of embryonic day (E) 15–19 Tg2576 mice (Charles
River Laboratories, MA), as described previously (Wu et al., 2004) with modifications. Briefly,
cortices were dissected, gently minced, trypsinized (0.027%, 37 °C; 5% CO2 for 15 min), and
then washed with 1×HBSS. Neurons were seeded to a density of 4 × 105 viable cells/35-mm
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culture dishes previously coated with poly-D-lysine (100 µg/ml) for at least 1 hour at 37 °C.
Cultures were maintained at 37 °C with 5% CO2, supplemented with neurobasal medium with
2% B27 nutrient, 2 mM L-glutamine, penicillin (100 units/ml) and streptomycin (100 µg/ml).
The cultures were used within 28 DIV. To maintain elevated levels of extracellular Aβ, media
was not changed. To identify the genotype of the animals, we used the polymerase chain
reaction on DNA extracted from sample tail taken after dissection of the cerebral cortex.
Adeno-associated Viral (AAV) Construction
AAV with an expression cassette of the chicken β-actin promoter driving EGFP or CaNwt or
CaNCA or AKAP79 peptide, flanked by the AAV ITRs, was described previously (Spires et
al., 2005). The mouse CaN isoform cDNA corresponding to wild-type (CaNwt), CaNCA
(amino acid residues 1–399), and a peptide corresponding to human AKAP79 (hAKAP79,
amino acid residues 60–358) were subcloned into AAV-CMV/CBA-WPRE vector. Each
construct was amplified by the following primers : ( 1 ) H A-CaNwt-V 5 5 ’ ,
GAATTCATGTATCCGTATGACGTACCAGAGTACGCCATGTCCGAGCCCAAGG
CGATTGATCC; (2) HA-CaNwt-V 5 3 ’ ,
GCTAGCTCACGTACTGTCGAGTCCCAGGAGAGGGTTTGGGATCGGCTTGCCC
TGGATATTGCTGCTATTACTGCCATTGC; (3) HA-C a N C A 3 ’ ,
CTAGTTCTGATGACTTCCTTCCGGGCTGCGGCCGTC; (4) Flag-hAKAP79 5’
GAAGTTATCAGTCGACATGGACTACAAAGACGATGACGACAAGGGCAGGAA
GTGTCCACAA; (5) Flag-h A K A P 7 9 3 ’ ,
ATGGTCTAGAAAGCTTCTAGACATTTTTAGATTTTGTAACATCAAATTCACTG
ATTTC. All the constructs were verified by sequencing.
Immunocytochemistry
Immunocytochemistry was performed as described previously (Wu et al., 2004). Briefly, after
being treated under different experimental conditions, cells were fixed with 4%
paraformaldehyde in phosphate-buffered saline (PBS) (pH 7.4) for 15 min and were then
membrane-permeabilized with 0.5% Triton X-100 in PBS for 5 min. After blocking with 3%
bovine serum albumin at 37 °C for 1 h, cells were incubated with primary antibodies: anti-
microtubule-associated protein 2 (MAP2) antibody (1:200, Sigma), or anti-NFATc4 antibody
(1:200, Santa Cruz), anti-HA antibody (1:200, Molecular Probes), or anti-flag antibody (1:200,
Sigma), at 4 °C overnight. Cells were then incubated with secondary antibodies conjugated to
either cyanine 3 (Cy3, 1:500; Jackson ImmunoResearch), or Alexa 488 (1:500; Molecular
Probes). Fluorescent images were obtained using a LSM 510 Zeiss microscope with a 25 × or
a 63 × water-imersion objective lens. All images were taken at 512 × 512 pixel resolution.
Nuclear NFATc4 staining was determined by overlap of NFATc4 staining with Hoechst
nuclear staining. To calculate the NFATc4 ratio of nucleus vs cytoplasm, the intensity of
nuclear NFATc4 was divided by the intensity of cytoplasmic NFATc4.
Immunohistochemistry
Immunohistochemistry was performed as described previously (Spires et al., 2005). Briefly,
animals were killed with an overdose of Ketamine (30 mg/kg) and Xylazine (3 mg/kg), and
the brain was fixed in 4% paraformaldehyde in phosphate buffer with 15% glycerol
cryoprotectant. Sections of 100 µm were cut on a freezing microtome, washed extensively in
0.1 M phosphate buffer and processed as free-floating slices. Permeabilization and blocking
was achieved by incubation of the sections for 1 h at room temperature in 0.1 M phosphate
buffer, 0.5% Triton X-100 (vol/vol) and 3% bovine serum albumin. Primary antibodies for
GFP (1:1000, Biogenesis), HA (1:100, Molecular Probes), Flag (1:100, Sigma), SMI312
(1:200; Sternberger Monoclonals) were applied overnight at 4 °C in 0.1 M phosphate buffer
with 3% bovine serum albumin. Following extensive washing, appropriate secondary
Wu et al. Page 3













antibodies conjugated to either Cy3 (1:100 dilution), Alexa 488 (1:100 dilution) or Cy5 (1:100
dilution) were applied for 1 hour at room temperature. Micrographs of immunostaining were
obtained using a 20 × objective with an upright Olympus Optical BX51 fluorescence
microscope with an Olympus Optical DP70 camera, or using a 63 × water-immersion objective
with a Zeiss confocal microscope.
Preparation of Subcellular Fractionation
Frozen tissue samples of human brain cortex (250 mg) were homogenized in 0.32 M sucrose
lysis buffer (0.32 M sucrose, 5 mM CaCl2, 3 mM Mg(Acetate)2, 0.1 mM EDTA, 10 mM Tris-
HCl (pH 8.0) and 0.1% Triton X-100), supplemented with complete protease inhibitor cocktail
tablets and centrifuged at 800 × g for 15 min at 4 degrees. The supernatants were centrifuged
at 100,000 × g for 1 hr at 4 degrees, and the resulting supernatants were regarded as the cytosolic
fractions. The pellets from the initial centrifugation step were resuspended in 1.8 M sucrose
buffer containing 1.8 M sucrose, 3 mM Mg(Acetate)2, 1 mM DTT and 10 mM Tris-HCl (pH
8.0), supplemented with complete protease inhibitor cocktail tablets (Roche Diagnostics, IN,
USA). The nuclei were pelleted by centrifugation at 12,400 × g for 1 hr at 4 degree. The pellet
was resuspended in 0.32 M sucrose buffer and washed by low-speed centrifugation. The final
pellet was designated as the nuclear fraction.
For western blot analyses, equal amounts of protein (20 µg) from each fraction were separated
on a 4–20% SDS-PAGE gel. Primary antibodies for CaN (Stressgen) and NFATc4 (Santa Cruz)
were utilized. Primary antibody incubation was followed by rabbit polyclonal horseradish
peroxidase linked secondary antibody (1:1000; Bio-Rad). Immunoreactivity was visualized
using enhanced chemiluminescence reagent (Perkin-Elmar) and exposure on x-ray film. Anti-
GAPDH antibody (Millipore) and anti-HDAC1 antibody (ABR-Affinity BioReagents) were
used to verify the integrity of the cytoplasmic and nuclear fraction separation.
Separation of Aβ oligomers by size exclusion chromatography (SEC)
5 ml of cultured media from 14DIV wild-type or Tg neuron cultures was collected and
centrifuged at 3,000 × g at 4 degrees in Amicon Ultra-15ML 3K(Millipore) to concentrate
proteins ~5 fold. 750 µl of concentrated cultured media was separated by SEC on Superdex
75 10/300 GL column (GE healthcare) in 50 mM ammonium acetate pH 8.5 with AKTA
purifier 10 (GE healthcare) (Townsend et al., 2006).
ToxiLight BioAssay
Cell viability was determined in wild type or Tg neurons at both 7DIV and 14DIV using the
ToxiLight BioAssay Kit from Lonza. Preparation of cell extracts and the cytotoxicity assay
were performed according to the manufacture's protocol.
Aβ Assay
Aβ levels were assayed from the medium collected from culture dishes at different date, using
an ELISA. Aβ concentration was determined with a sandwich ELISA kit (WAKO, Richmond,
VA) and with BAN50/BA27 for Aβ40 and BAN50/BC05 for Aβ42 in cultured medium and
with BNT77/BA27 for Aβ40 and BNT77/BC05 for Aβ42 in fractionated samples by size-
exclusion chromatography. Samples was optimized to detect Aβ in the range of 6.25–100 fmol/
ml. ELISA signals were reported as the mean ± SD of two replica wells in fmoles of Aβ per
mg of protein (determined with the BCA Protein Assay Reagen Kit, Pierce).
Immunoprecipitation Aβ from Cultured Medium
Cultured medium of wild-type or Tg cultures at 14 DIV were collected. Medium was
centrifuged at 1200 rpm for 5 min at 4 °C to remove cellular debris. Supernatants (1.3 ml) for
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each condition were precleared with 50 µl protein G sepharose (Sigma) for 1 hour at 4 °C with
gentle shake, then centrifuged at 15,000 rpm at 4°C for 5 min. Supernatants were incubated
with 5 µg anti-6E10 antibody or 5 µg anti-GFP (Abcam) as control. After an overnight
incubation at 4 °C, protein G sepharose (60 µl) were added and incubated at 4 °C for 2 h. Beads
were isolated by centrifugation (15,000 rpm, 4°C for 5 min) and subsequently washed three
times with TBS buffer before the addition of 2× Laemmli sample buffer.
[Ca2+]i Measurements
Primary neurons were plated on 35 mm glass-bottom dishes (MatTek, Ashland MA) and
maintained in a standard Neurobasal medium without Phenol Red. Calcium levels were
evaluated in wild type neurons treated for 24 hours with wild type or Tg conditioned media as
well as with transgenic conditioned media that was pre-depleted with 3D6 antibody. In all
cases, calcium imaging was performed using Indo-1 as previously described(Bacskai et al.,
2000). Briefly, Indo-1/AM (Molecular Probes) was dissolved with 20% pluronic F-127
(Molecular Probes) in DMSO and then added to the culture dishes at a final concentration of
1 µM Indo-1/AM and 0.02% pluronic F-127 for 45 min. Cells were imaged with an Olympus
Fluoview 1000MPE with pre-chirp optics and a fast AOM mounted on an Olympues BX61WI
upright microscope and an Olympus 20× dipping objective (numerical aperture 0.95). A mode-
locked titanium/sapphire laser (MaiTai; Spectra-Physics, Fremont, CA) generated two-photon
fluorescence with 750nm excitation, and the emitted light was discriminated into two channels
with interference filters corresponding to 390-nm, 65-nm band pass and 495-nm, 20-nm band
pass (Chroma Technology, Brattleboro, VT) for ratiometric imaging. The capture settings
remained unchanged for the entire experiment. Fluorescence emission ratios were calculated
in the neuronal cell bodies. To convert the calculated ratios into calcium concentrations,
primary neurons were incubated with Indo-1/AM and treated with either calcium free or 39µM
calcium buffers in the presence of 20µM ionomycin for 15 min. The calcium free and calcium
saturated ratios were then measured and used as the Rmin and Rmax. These ratio along with the
KD of Indo-1 for calcium of 250nM (Grynkiewicz et al., 1985) were used for calculation of
calcium concentration.
Luciferase Reporter Assay
Mouse wild-type CaNA isoform (CaNwt), truncated CaNA encoding 45-kDa (CaNCA)
isoform, or NFAT-TA-Luc (BD Biosciences Clontech), were subcloned into Adeno-associated
virus (AAV serotype 2) vector. These plasmids (1 µg) were used primary neurons at 3 DIV.
After 24 h, the cells were harvested and luciferase activities were measured with a luminometer
using a reagent kit (Luciferase Assay System with Reporter Lysis Buffer, Promega). The
background luciferase activity was subtracted from all experiments.
Experimental Animals
C57Bl/6J wild-type mice and double transgenic mice (B6C3APPswe/PS1dE9 line, Jackson
laboratory) overexpressing mutant human APP and mutant human Presenilin 1, as well as
transgenic mice expressing human Swedish mutated APP (Tg2576 line) were used. These mice
were housed in the animal facility and C57Bl/6J wild-type and APP/PS1 mice were used at
the age of 5–6 months for intracortical injection. All experiments were performed in accordance
with animal protocols approved by the Institutional Animal Care and Use Committee.
Intracortical Injections and Surgery
Intracortical injections and surgery were performed as described previously (Spires et al.,
2005; Kuchibhotla et al., 2008; Meyer-Luehmann et al., 2008). Briefly, mice were anesthetized
with Ketamine (10 mg/kg) and Xylazine (1 mg/kg) and placed in a stereotaxic apparatus. The
surgical site was sterilized with betadyne and isopropyl alcohol, and a 2–3 mm incision was
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made in the scalp along the midline between the ears. Burr holes were drilled in the skull, 0.5
mm posterior from bregma and 0.5 mm lateral to the midsagital line. Using a Hamilton syringe,
3 µl of virus (titer, 4.2 × 1012 viral genomes/ml) was injected 1.2 mm deep in somatosensory
cortex at a rate of 0.25 µl/min. After one injection in each burr hole, the scalp was sutured, and
the mouse recovered from anesthesia on a heating pad.
3–4 weeks after injection, APP/PS1 transgenic mice received an intraperitoneal injection of
methoxy-XO4 (10 mg/kg), a fluorescent compound that crosses the blood-brain barrier and
binds to amyloid plaques (Klunk et al., 2002). A cranial window of 6 mm in diameter was
installed under anesthesia (Ketamine (10 mg/kg) and Xylazine (1 mg/kg)). At the same time,
Texas Red dextran (70,000 Da molecular weight; 12.5 mg/ml in sterile PBS; Molecular Probes,
Eugene, OR) was injected into a lateral tail vein to provide a fluorescent angiogram.
Multiphoton Imaging
Images of GFP-filled neuronal processes, and, in the case of APP/PS1 mice, amyloid
pathology, and blood vessels were obtained using a Bio-Rad 1024ES multiphoton microscope
(Bio-Rad), mounted on an Olympus Optical (Tokyo, Japan) BX50WI upright microscope. A
wax ring was placed on the edges of the coverslip of the cortical window and filled with distilled
water to create a well for an Olympus Optical 20× dipping objective (numerical aperture, 0.95).
A mode-locked titanium/sapphire laser (MaiTai; Spectra-Physics, Fremont, CA) generated
two-photon fluorescence with 800 nm excitation, and detectors containing three
photomultiplier tubes (Hamamatsu, Ichinocho, Japan) collected emitted light in the range of
380–480, 500–540, and 560–650 nm (Bacskai et al., 2003). GFP-filled were sampled ~100
microns below the surface of the brain around somatosensory cortex. At the end of imaging
sessions, mice were allowed to recover and placed singly in their home cage.
Labeling of Fibrillar Amyloid Deposits
Following immunohistochemistry, fibrillar amyloid deposits (neuritic plaques) were stained
for 8 min in a solution of thioflavin S (2 µg/mL) in 0.1 M PBS and then rinsed with ddH2O.
Statistical Analyses
Data are presented as mean ± standard deviation (SD). We made comparisons between groups
by one- or two - way ANOVA followed by post-hoc Bonferroni's test for comparison among
means. Differences with a P value of < 0.05 were considered statistically significant.
Results
Abnormal morphologies in neurons from Tg 2576 cultures
Neuritic abnormalities are seen surrounding plaques in human AD and in aged APP
overexpressing mouse models of AD, but studying these lesions is difficult since they are
distributed apparently randomly throughout the cortical mantle, occur only in aged animals,
and the location of new lesions cannot be predicted. We sought to develop a tractable model
for neuronal abnormalities associated with AD. We first examined whether mature primary
neurons from transgenic embryos expressing APP with the familial Swedish (APP-SW)
mutation (Tg 2576 line) develop any of the morphological phenotypes associated with
neurodegeneration in the intact (aged) transgenic brain and in human AD including dendritic
spine loss, diminished dendritic complexity, and neuritic dystrophies. To assess neuronal
morphology, we transfected cultured neurons with green fluorescent protein (GFP) to label
individual neurons. During the course of 21 days in vitro (DIV), GFP positive neurons from
Tg 2576 (Tg) cultures progressively develop a neurodegenerative phenotype when compared
to neurons from wild-type mice. In wild-type neurons at 14 DIV, GFP fluorescence
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demonstrated intricately branched dendritic arbors studded with protrusions that included
mature spines and few fillopodia (Fig. 1A1 and 1A3). However, in Tg neurons the maturation
is accompanied by an increase in the number of neurons with focal neuritic swellings (Fig.
1A2 and 1A4). The difference is marked; for example, at 14 DIV (Fig. 1B), the number of
neurons with beaded neurites in Tg cultures is 7-fold higher than those in wild-type cultures.
In addition, the number of neurons with dystrophic neurites increased with time (Fig.1B). In
Tg cultures, GFP-positive neurons with dystrophies are found in 14% of neurons at 14 DIV
and in 24% at 21 DIV. Since some subtle morphological changes other than dendritic
dystrophies, such as decreased dendritic branches and spine density, are also observed in the
early stages of neurodegeneration, we next compared dendritic branching and the density of
dendritic spines of GFP-positive neurons from Tg and wild-type cultures. As measured by
Sholl analysis, neurons in Tg cultures had reduced dendritic complexity at all points farther
than 30 µm from the cell body compared to wild-type cultures (Fig. 1C and D). These effects
are not due solely to processes with overt morphological changes like dystrophies. For example,
comparison of spine density in neurons (excluding neurons with dystrophies) between Tg and
wild-type cultures showed that the mean spine density of Tg neurons is markedly lower than
that of wild-type neurons (Fig. 1E and F). These effects are not due to overt toxicity; No typical
apoptotic nuclei (chromatin condensation) appeared in Tg neurons compared with wild-type
neurons (supplemental Fig. 1A). ToxiLight assay for cell death showed no significant
difference between wild-type and Tg neurons at either 7 or 14DIV (supplemental Fig. 1B).
Taken together, these results indicate that neurons with abnormal morphologies are limited in
wild-type cultures, whereas in Tg cultures, neurons develop dystrophies, profound dendritic
simplification, and loss of dendritic spines.
Conditioned media from Tg culture contains oligomeric Aβ and induces elevation of [Ca2+]i
Primary cortical neurons derived from Tg embryos at 14 DIV produced high levels of two
major types of human Aβ peptides, Aβ 40 and 42; the concentration of Aβ 40 was 16 ng/ml
and of Aβ 42 was 1.2 ng/ml as determined by ELISA assay (supplemental Fig. 2A and B).
Moreover, IP Western blot analysis revealed the presence of readily detectable SDS-stable
small oligomers in CM of Tg cultures at 14 DIV, similar to those reported to be synaptotoxic
(Shankar et al., 2008) (supplemental Fig. 2C).
We recently observed that neurites in the region near senile plaques contain high [Ca2+]i
(Kuchibhotla et al., 2008). To examine if Aβ is capable of inducing an increase in [Ca2+]i, we
studied the effect of Tg neuronal culture CM on calcium homeostasis of wild-type neurons.
Wild-type cortical neurons were cultured in standard NB/B27-serum free medium and at 14
DIV, the medium was replaced with diluted 1:2 CM from wild-type or Tg cultures and further
incubated for 24 hrs. As shown in supplemental Fig. 2D, wild-type neurons treated with Tg
CM for 24 hrs exhibited elevated levels of [Ca2+]i compared to neurons maintained in wild-
type CM for 24 hrs. There was no significant difference in [Ca2+]i levels between untreated
neurons and neurons treated with wild-type CM (wtCM) for 24 hrs, indicating that the elevated
levels of [Ca2+]i specifically resulted from Tg CM. To determine if Aβ caused the elevation
of the [Ca2+]i, we compared [Ca2+]i between neurons applying Tg CM with or without
immunodepletion using 3D6 antibody, a high-titre monoclonal Aβ antibody (Johnson-Wood
et al., 1997). 3D6 immunodepletion completely prevented the elevation of [Ca2+]i
(supplemental Fig. 2D).
CaN / NFATc4 - aberrant nuclear localization in neurons from Tg cultures and human AD
postmortem brain
Since Aβ in Tg CM induces elevated [Ca2+]i in cultured neurons, and our previous study
showing that neurites with abnormal morphologies in both APP/PS1 and APP transgenic mice
were strongly associated with [Ca2+]i overload (Kuchibhotla et al., 2008), we examined
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Ca2+ mediated pathways as the link between exposure to Aβ and a neurodegenerative
phenotype. As CaN is the most calcium sensitive protein phosphatase in the brain (Klee et al.,
1979), we examined whether CaN activity is upregulated in neurons from Tg cultures.
NFATc4, the nuclear factor of activated T cells, is a well-known CaN substrate. Activation of
the predominant neuronal NFATc4 isoform, which is abundantly expressed in cortical neurons,
can be determined by its nuclear translocation following CaN-mediated dephosphorylation.
Cultured neurons were stained with an antibody against endogenous NFATc4, a Hoechst
counterstain for identification of nuclei, and MAP2, a neuron marker (Fig. 2A). The NFATc4
immunofluorescence intensity was measured and the ratio of the intensity (nucleus vs
cytoplasm) was compared in neurons from wild-type and Tg cultures. Very little colocalization
of Hoechst nuclear staining and NFATc4 was found in wild-type neuron cultures, indicating
that inactive NFATc4 is mostly located in the cytoplasm, whereas in Tg culture, NFATc4
staining was enhanced in nuclei (Fig. 2A and B). Similarly, CaN is known to translocate to the
nucleus when activated, and Tg neuron cultures showed higher immunofluorescence intensity
of CaN in the nucleus compared to wild-type neurons (Fig. 2C and D). These data show that
CaN and NFAT are activated in Tg neurons.
To determine whether the aberrant nuclear localization of CaN / NFATc4 observed in Tg
neurons could be relevant to the AD human condition, total homogenates, cytosol, and nuclei
were prepared from frozen human AD or control cortex tissue samples and analyzed by
immunoblotting with antibodies against endogenous NFATc4 or CaN (supplemental table 1
and Fig. 2). NFATc4 immunoreactivity in the nuclear fraction prepared from AD samples was
markedly increased compared to that seen in control samples, but no changes were observed
in either the total homogenate or cytoplasmic fractions (Fig. 2E, F and G). Immunoblot analysis
with CaN showed similar intensity of full-length CaN in all three compartments between AD
and control (Fig. 2H). By contrast, we observed a consistent 2.2-fold increase in the level of a
45-kDa fragment of CaN, a post-translationally truncated form of CaN (CaNCA), which is
constitutively active, in the nuclear fraction in AD samples compared with control samples
(Fig. 2I). This proteolytic product removes the autoinhibitory C-terminal domain, and has been
observed as a mechanism of CaN activation in stroke, trauma, and glaucoma (Morioka et al.,
1999; Wu et al., 2004; Burkard et al., 2005; Huang et al., 2005). Taken together, the aberrant
accumulation of nuclear NFATc4 and constitutively active form of CaN indicate aberrant
activation of CaN / NFATc4 signaling in AD. These results confirm the observation of
truncated CaN in AD by Liu et al (Liu et al., 2005), but appear to contrast with those of Celsi
et al (Celsi et al., 2007) who observed diminished CaN immunoreactivity in neurons in AD,
perhaps because the latter study did not distinguish full length from truncated forms.
Conditioned media of Tg culture and Aβ oligomers isolated by Size Exclusion
Chromatograpy (SEC) - induces NFATc4 nuclear translocation in wild-type neurons, which
is blocked by Aβ immunodepletion or CaN inhibition
Soluble plaque-associated bioactive molecules, possibly assemblies of Aβ, may be responsible
for the “halo” effect of neuritic change and [Ca2+]i alterations near plaques (Kuchibhotla et
al., 2008; Meyer-Luehmann et al., 2008; Koffie et al., 2009). To examine this possibility, we
studied the effect of Tg neuronal culture conditioned medium on CaN activation and neurite
properties of wild-type neurons. Wild-type cortical neurons were cultured in standard NB/B27-
serum free medium and at 14 DIV, the medium was replaced with diluted 1:4 CM from wild-
type or Tg cultures for 24 hrs. As shown in Fig. 3B and C, neurons treated with wtCM for 24
hrs exhibited a relatively low nucleus/cytoplasm ratio of NFATc4, which was similar to
neurons in culture without CM replacement. In contrast, neurons treated with Tg CM for 24
hrs demonstrated a significant increase in the nucleus/cytoplasm ratio of NFATc4 compared
to neurons maintained in wtCM. The increased ratio was considerably reduced in neurons
overexpressing an adeno-associated virus encoding an epitope-tagged (flag) AKAP79
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fragment (AAV-AKAP79), a potent CaN inhibitory peptide (Coghlan et al., 1995) (Fig. 3A).
Immunodepletion of Aβ from the Tg CM with 3D6 prevented the increase in the nucleus/
cytoplasm ratio of NFATc4 (Fig. 3B and C), suggesting that soluble Aβ species in the Tg CM
mediated activation of CaN and NFATc4 nuclear translocation. To better characterize the
specific role of Aβ oligomers in CaN-mediated NFATc4 activation, non-denaturing SEC was
used to isolate the various Aβ species from Tg CM. Both ELISA and Western blot analysis
showed that SEC fractions 17–20 of Tg CM, but not the same fractions of wtCM, were
markedly enriched in either oligomeric forms of Aβ 40 and 42 (supplemental Fig. 2E, F and
G). Application of SEC fractions 18–19 (oligomeric Aβ fraction) of Tg CM onto wild-type
neurons for 24 hours caused a significant increase in translocation of NFATc4 to the nucleus,
but no changes were observed in neurons treated with the same SEC fractions of wtCM.
Immunodepletion of Aβ from the fractions 18–19 of Tg CM with 3D6 prevented the increase
in the nucleus/cytoplasm ratio of NFATc4 (Fig. 3D). Wild type neurons treated with fractions
6–7 (sAPP fraction, supplemental Fig. 2E, F and G) either from Tg CM or wtCM showed no
significant difference in the nucleus/cytoplasm ratio of NFATc4. These results suggest that
either Aβ containing CM from Tg culture or SEC-isolated Aβ oligomers is capable of inducing
CaN-mediated NFATc4 activation.
Aβ containing conditioned medium causes morphological abnormalities in wild-type
neurons identical to those observed in Tg neurons in culture
To test whether the abnormal morphology observed in Tg cultures is caused by Aβ, we
examined wild-type cultured cortical neurons growing in either Tg or wild-type CM starting
24 hrs after plating and maintained in CM until neuron maturity (24 DIV). As shown in Fig.
4A, wild-type cultures maintained in Tg CM exhibited a significantly higher number of neurons
with focal neuritic dystrophies compared to cultures maintained in wtCM. Cultures maintained
in Tg CM that was pre-immunodepleted by 3D6, but not boiled 3D6, had a lower number of
neurons with dystrophies similar to that seen in cultures growing in wtCM. Sholl analysis
indicated that neurons growing in Aβ containing Tg CM also had dendritic simplification, but
this is not the case in cultures maintained in Tg CM that was immunodepleted by 3D6 (Fig.
4B and C). A striking effect of Tg CM on dendritic spine density was also noted. The density
of dendritic spines in the neurons growing in Tg CM was greatly decreased (Fig. 4D). There
was no significant reduction of spine density between neurons growing in wtCM and Tg CM
that was immunodepleted by 3D6, whereas spine density from neurons growing in Tg CM that
was treated with inactive, boiled 3D6 was also significantly reduced. In addition, Tg neurons
grown in media immunodepleted with 3D6 at 3 DIV no longer developed dystrophic
morphology during maturation. We detected no statistically significant difference in the
number of neurons with dystrophies (Fig. 4E), dendritic complexicity (Fig. 4F and G), or the
mean spine density (Fig. 4H), between wild type and Tg neurons treated with media that had
been immunodepleted by 3D6. These results suggest that Aβ immunodepletion blocks
neurodegenerative morphologies that occur in neurons exposed to Aβ-containing CM, or that
overexpress APP.
Inhibition of either CaN activity or CaN-mediated NFAT activation abolishes Tg CM or APP
overexpression induced morphological abnormalities
Both CaN-mediated NFATc4 activation and abnormal morphologies were detected in Tg
neurons and in wild-type neurons growing in Tg CM. We reasoned that Aβ might cause the
morphological changes via CaN activation, or CaN activation and morphologic changes might
each be unrelated effects of Aβ treatment. To address whether CaN is involved in the
development of Aβ-related abnormal morphologies, wild-type neurons growing in Tg CM at
3DIV were transduced with an AAV encoding a CaN inhibitory peptide AKAP79. At 14 DIV
essentially 100% of neurons expressed AKAP79 by measuring the co-localization of flag-tag
positive neurons and MAP2 stained neurons (supplemental Fig. 3A). Tg neurons
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overexpressing AKAP79, but not a control vector, AAV-β-galactosidase, contained
significantly fewer neurons with beaded processes at 21 DIV (Fig. 5A). AKAP79
overexpression abolished Tg CM induced dendritic simplification as assessed by Sholl analysis
(Fig. 5B and C) and reduction in dendritic spine density (Fig. 5D). In addition, Tg neurons
overexpressing AKAP79 inhibitory peptide at an early time point (3 DIV) no longer developed
dystrophic morphology during maturation. We detected no statistically significant difference
in the number of neurons with dystrophies (Fig. 5E), dendritic complexity (Fig. 5F and G), and
the mean spine density (Fig. 5H), between wild-type and Tg neurons overexpressing AKAP79
inhibitory peptide. FK506, a potent inhibitor of CaN with an independent mechanism of action,
also blocked TgCM induced dendritic spine loss (supplemental Fig. 3B). These results suggest
that CaN inhibition blocks neurodegenerative morphologies that occur in neurons exposed to
Aβ-containing CM, or that overexpress APP.
CaN-mediated activation of NFAT has been demonstrated to play an important role in axonal
outgrowth and activity-dependent dendritic structural changes during development (Graef et
al., 2003; Groth and Mermelstein, 2003; Schwartz et al., 2009). Our present study indicates
that nuclear accumulation of NFATc4 occurs in neurons from Tg cultures and in human AD
postmortem brain, and that Aβ containing CM from Tg culture is capable of inducing CaN-
mediated NFATc4 nuclear localization in wild type neurons. To clarify the signaling pathway
activated by CaN that could involve CaN-dependent morphological neurodegeneration during
Aβ neurotoxicity, we examined the effect of 11R-VIVIT (VIVIT), a cell-permeable peptide
that blocks the docking sites for CaN-NFAT interaction and therefore specifically inhibits CaN-
mediated NFAT activation without impacting other CaN substrates (Aramburu et al., 1999).
Application of 2 µM VIVIT to wild type neurons growing in Tg CM abolished Tg CM induced
NFAT nuclear accumulation (supplemental Fig. 3C and D), and blocked morphological deficits
induced by Aβ, including reduced numbers of neurons with dendritic dystrophies (Fig. 6A),
increased dendritic complexicity (Fig. 6B and C) and spine density (Fig. 6D). Similarly, Tg
neurons treated with VIVIT showed dramatically improved morphology in comparison with
Tg neurons treated with carrier (DMSO) (Fig. 6E, F, G and H). No significant changes in
number of neurons with dendritic dystrophies, dendritic processes and spine density were
detected in wild-type neurons treated with VIVIT or DMSO, suggesting that inhibition of CaN-
NFAT interaction at the concentration that we are using does not have a strong effect on
baseline maturation. Thus, inhibition of CaN-NFAT interaction and subsequent NFAT nuclear
accumulation by VIVIT blocks Tg CM or APP overexpression induced morphological
abnormalities in culture. These data indicate that upregulation of CaN activity by Aβ activates
the NFAT cascade, resulting in a pathological triad of dendritic spine loss, dendritic
simplification, and neuritic dystrophies.
Transduction of a CaNCA into wild-type cultured neurons induces abnormal morphology
which is a phenocopy of the Aβ effect
To examine whether CaN activation is sufficient to cause these morphologic changes, even in
the absence of overexpressed APP or exogenously applied Aβ, we investigated whether the
expression of a CaNCA would favor morphological changes in wild-type cultured neurons.
An AAV vector encoding a HA-tagged CaNCA (AAV-CaNCA) or wild-type CaN (AAV-
CaNwt), or an AAV-vector control was expressed in cortical cultures. HA-tag immunostaining
showed that nearly all MAP2 stained neurons expressed AAV-CaNwt or AAV-CaNCA, and
neurons overexpressing CaNCA had significantly increased NFAT-luciferase activity, which
was blocked by AKAP79 inhibitor peptide (supplemental Fig. 4A and B). As shown in Fig.
7A and B, neurons with swollen dendrites were barely detectable in CaNwt overexpressing
cultures, but they were prominently detected in CaNCA overexpressing cultures.
Approximately 15% of total GFP-positive neurons were observed to have typical local neuritic
dystrophies in cultures overexpressing CaNCA (Fig. 7A and B), whereas, 6% of total GFP-
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positive neurons developed dystrophies in CaNwt expressing cultures. The latter is similar to
the number of dystrophic neurites found in cultures expressing β-galactosidase, an AAV-vector
control. Dendritic complexicity (Fig. 7C and D) and mean spine density (Fig. 7E and F) were
reduced in neurons overexpressing CaNCA, but not in CaNwt or vector overexpressing
neurons. Inclusion of AKAP79 inhibitory peptide or VIVIT virtually eliminated CaNCA
overexpression induced dendritic spine loss (supplemental Fig. 4C), suggesting that NFAT
activation is critical for CaNCA-induced dendritic spine loss. These data indicate that ectopic
expression of CaNCA is sufficient to cause neuritic dystrophies, dendritic simplication, and
spine loss in neurons in culture.
CaNCA induces abnormal neuronal morphologies in vivo
To investigate the role of elevated CaN activity on neuronal morphology in the intact adult
mouse brain, we next introduced high-titer AAV-CaNCA, AAV-CaNwt, or AAV-β-
galactosidase, along with AAV-GFP, intracranially into the somatosensory cortex or
hippocampus of C57Bl/6J mice by stereotaxic injection, as described in Materials and Methods.
Three to four weeks after intracranial injection, GFP-filled neurites and corresponding spines
were detectable in the live animals using multiphoton microscopy (Fig. 8C)(Spires et al.,
2005). GFP labeled neurons were also observed in limited cortical and hippocampal areas in
post mortem sections stained with a GFP antibody (Fig. 8A). We confirmed, with HA-tag
staining, that almost all of the GFP positive cells were immunoreactive for CaNwt (or CaNCA),
showing that GFP labeled neurons also expressed CaNwt or CaNCA (supplemental Fig. 5A).
Compared with neurons expressing control vector or CaNwt, CaNCA expressing neurons
showed high levels of NFATc4 nuclear distribution (supplemental Fig. 5A). The dendritic
morphology of GFP-labeled neurites from cortical and hippocampal areas of wild-type mice
injected with CaNCA displayed neurodegenerative alterations. Dystrophies were observed
along the length of dendrites (Fig. 8B2) or axons (Fig. 8B4), whereas, dendrites or axons from
these area of mice injected with CaNwt showed normal processes (Fig. 8B1, B3), similar to
those seen in vector control injected mice. High power images from multiphoton observations
of the live brain allowed analysis of dendritic spines, which showed that, compared to the
control, spine density was significantly decreased in mice injected with CaNCA, whereas
CaNwt injected mice showed mean spine density comparable to control vector injected mice
(Fig. 8C and D).
Overexpression of a genetically encoded CaN inhibitor AKAP79 inhibitory peptide reduces
Aβ associated neurodegenerative alterations in vivo
To directly determine the effect of CaN inhibition on the Aβ-related morphological
abnormalities in the adult rodent brain in vivo, AAV-AKAP79 inhibitory peptide or a vector
control was co-injected with AAV-GFP into somatosensory cortex in 6-month-old living APP/
PS1 mice. With multi-photon imaging, we were able to quantitatively compare neuritic
dystrophies (size of dystrophies defined as areas of swelling >2.5 µm in diameter), neurite
curvature, as well as spine density near (< 50 µm) or far (> 50 µm) from amyloid deposits in
living APP/PS1 mice. As shown in Fig. 9, the mean size of dystrophies near plaques from
control vector injected brain was significantly larger than that found in brain injected with
AKAP79 (Fig. 9A2, A3 and B). Compared to the vector control, spine density was significantly
increased near plaques in mice injected with AKAP79 inhibitory peptide (Fig. 9C).
Another well-characterized morphological alteration in both APP over-expressing mouse brain
and human AD is the development of tortuous, nonlinear trajectories for neurites, especially
near plaques (Knowles et al., 1999; Le et al., 2001). This tortuosity is measured by “neuronal
curvature”, a marker of how straight a neurite segment is (Knowles et al., 1999). Compared to
the elevated neuritic curvature seen at baseline in the APP/PS1 mice, we observed a significant
improvement in neurite curvature in AKAP79 inhibitory peptide injected mice (Fig. 9D). Both
Wu et al. Page 11













GFP and AKAP79 inhibitory peptide were co-expressed in the vast majority of neurons
(supplemental Fig. 5B). Examination of Aβ deposits revealed no changes in the Aβ deposits
themselves associated with AAV injection.
To exclude the possibility that in vivo imaging of GFP in neuritic dystrophies might not be
representative, we examined SMI312 immunoreactivity, which recognizes a neurofilament
protein that labels all axons, in postmortem sections. In the postmortem samples in control
areas not expressing AKAP79 inhibitory peptide, axons in close proximity to Aβ deposits had
abnormal large dystrophies as expected (Fig. 9E1). By contrast, substantially fewer axons in
the AKAP79 inhibitory peptide injected areas in close proximity to Aβ deposits showed
dystrophies (Fig. 9E2 and 9F). Consistent with the live imaging data, the mean size of
dystrophies from control vector injected brain was significantly larger than those found in areas
injected with AKAP79 inhibitory peptide (data not shown). Together, these results show that
CaN inhibition blocks the neurodegenerative changes that are well-established to occur in the
immediate vicinity of Aβ plaques in vivo, without affecting the Aβ deposits.
Discussion
Although it has been clear for a century that amyloid plaques are surrounded by neuritic
abnormalities, and the amyloid hypothesis of AD suggests that Aβ peptide induces downstream
neurodegenerative changes leading ultimately to collapse of neural networks and clinical
dementia (Hardy and Allsop, 1991; Hardy and Selkoe, 2002), the molecules and mechanisms
underlying the translation of Aβ neurotoxicity into morphological disruption remain undefined.
Here we present data that support the idea that activation of CaN and subsequent NFAT-
mediated downstream cascades are key molecular mechanisms linking Aβ to damage of the
structural underpinnings of neural networks. This molecular model of neuronal degeneration
is initiated by Aβ inducing calcium influx and CaN activation, which causes NFAT nuclear
accumulation, leading to a pathological triad of dendritic spine loss, dendritic simplification,
and neuritic dystrophies. Importantly, we show reversal of morphological neurodegenerative
phenotypes in vitro and in vivo with a neuroprotective strategy of CaN inhibition, providing
an important proof in principle of a non-Aβ directed therapeutic intervention that improves
neuronal structure in an AD model.
Memory loss in AD patients is correlated strongly with synaptic dysfunction (DeKosky and
Scheff, 1990; Terry et al., 1991; Sze et al., 1997). CaN is a protein phosphatase that plays a
fundamental role in memory formation through mechanisms controlling synaptic function
(Malleret et al., 2001; Winder and Sweatt, 2001; Mansuy, 2003). Mice with inducible,
hippocampal-restricted overexpression of CaNCA exhibit pronounced spatial learning and
memory deficits in the Morris water maze task (Mansuy, 2003). The defect of learning
behaviors is reversible in transgenic mice expressing a CaN inhibitory domain or application
of antisense oligonucleotides (Malleret et al., 2001; Mansuy, 2003). These results suggest that
synaptic dysfunction and memory retention deficits that occur in AD patients and animal AD
models may result, at least in part, from altered CaN activity. Indeed, CaN inhibition with
FK-506 has been reported to improve memory function in APP transgenic mice (Dineley et
al., 2007; Taglialatela et al., 2009).
In the present study, we have shown that neurons from Tg cultures exhibit increased NFATc4
nuclear translocation (Fig. 2A and B), which is known to be regulated by CaN activation. The
NFATc4 - aberrant nuclear localization can also be induced by Tg CM, which contains high
levels of naturally secreted Aβ, and this can be blocked by immunodepletion of the Tg CM
with an Aβ-specific antibody, by the potent CaN inhibitory peptide AKAP79, or by treatment
with VIVIT which blocks NFAT activation (Fig. 3B and C, supplemental Fig. 3C and D).
Importantly, the NFATc4 - aberrant nuclear localization and a constitutively active form of
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CaN were also found in AD postmortem brain, indicating that CaN activation and the resulting
downstream NFAT transcriptional cascade also occurs in AD. Moreover, in cultures, CaN
inhibition or blockade of NFAT activation using VIVIT provided significant neuroprotection
from Tg CM or APP overexpression induced morphological deficits (Fig. 5 and Fig. 6).
CaN activation has profound effects on neuronal morphology. We show, both in cultures and
in wild-type adult mouse brain in vivo, that manipulation of CaN activity by ectopic expression
of CaNCA is sufficient to cause segmental spine loss, dendritic simplification and focal
swelling similar to Aβ-induced morphological aberrations (Fig. 7 and Fig. 8). In mouse models
of AD, CaN inhibition potently reduces the Aβ-related morphological neurodegenerative
changes that occur near plaques (Fig. 9). These data suggest a pivotal novel role of CaN
activation and CaN-mediated NFAT signaling pathway in Aβ-related morphological
neurodegeneration, providing a mechanistic link between calcium overload, activation of CaN,
and Aβ-induced neuronal morphological destruction of neural systems.
There are three major implications of these studies. First, our results confirm that Aβ induces
CaN activation in vitro and in AD (Liu et al., 2005; Snyder et al., 2005; Hsieh et al., 2006;
Agostinho et al., 2008; Reese et al., 2008; Abdul et al., 2009); we now show that CaN activation
in neurons causes the pathological triad of dendritic spine loss, dendritic simplification, and
dystrophies. Although it seems likely that activation of CaN has multiple effects, including
functions at the dendritic spines itself (Hsieh et al., 2006), and it remains possible that VIVIT
disrupts CaN functions other than NFAT dephosphorylarion (Oliveria et al., 2007), our data
are consistent with the possibility that NFAT mediated cascades play a prominent role in the
neurodegenerative process. These results clearly implicate a soluble form of Aβ, likely
oligomeric, as the responsible bioactive molecule that is present in the vicinity of plaques that
mediates the neuronal alterations that occur within a halo near plaques (Koffie et al., 2009).
Importantly, these results allow the development of a simple in vitro model of Aβ-induced
neurodegeneration (TgCM treatment of wild-type neurons for 24 hrs) that has predictive value
for plaque-induced neurodegeneration in 8–12 month old transgenic animals.
Secondly, activated CaN produces a phenocopy of these Aβ effects. Importantly, either
immunodepletion of Aβ, inhibition of CaN, or blockade of NFAT alone can inhibit these
changes and lead to recovery of neuronal structure. Previous studies have shown some recovery
of neuronal lesions after treatment with antibodies directed against Aβ (Lombardo et al.,
2003; Brendza et al., 2005; Spires-Jones et al., 2008). Since our current data show that CaN
activation is downstream of soluble Aβ neurotoxic effects, it seems likely that a strategy aimed
at preventing or restoring CaN-mediated neural system damage, combined with approaches
that reduce Aβ generation or promotes its clearance, may be more effective than either strategy
alone. The higher enrichment of activated CaN and NFATc4 in the nuclear fraction of cortex
from AD patients (Fig. 2E–I) reinforces the importance and disease-relevance of these
observations. Thus, CaN inhibition or blockade of NFAT or its targets may be an important
avenue for consideration in AD therapeutics.
Thirdly, our results suggest for the first time that CaN and NFAT play a major role in sculpting
neural systems in the mature brain, implying that the adult brain is not “hard wired”. A
prominent role for CaN has been long established in learning and memory (Malleret et al.,
2001; Winder and Sweatt, 2001; Zeng et al., 2001; Mansuy, 2003) and CaN activation is
important in phenomena such as long term depression. A recent study suggests that CaN /
NFAT signaling is responsible for dendritic simplification during developmental pruning of
the Xenopus neural system (Schwartz et al., 2009). However, a major role for CaN-NFAT
mediated transcriptional events in dendrite remodeling in the adult brain or in disease
conditions as observed here has not been previously reported. Since aberrant CaN activation
has been implicated in CNS trauma, ischemia, Kainate injury, and glaucoma (Morioka et al.,
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1999; Springer et al., 2000; Wu et al., 2004; Huang et al., 2005; Uchino et al., 2008), each of
which leads to neural system degeneration, we postulate that the type of structural remodeling
and morphological degenerative changes observed in multiple conditions might be a
consequence of CaN activation. Intriguingly, it appears as if the major effects of CaN in AD
may be mediated by NFAT, implying a potential unexplored role for transcriptional cascades
in these conditions. Thus, a molecular mechanism of neurodegeneration in AD may be Aβ-
induced aberrant activation of a potent NFAT-mediated developmental program of neural
system remodeling, suggesting possible therapeutic avenues for rescue.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Abnormal morphologies in neurons from Tg cultures. (A) Representative images of a wild-
type GFP-labeled neuron at 14 DIV shows intricately branched dendritic arbors (A1 and A3),
whereas Tg neurons exhibit simplified dendritic complexity and localized dendritic dystrophies
(A2 and A4). (B) The percentage of neurons with dendritic dystrophies at 14 DIV and 21 DIV
was increased in Tg neurons compared to wild-type. (14 DIV, wt cultures: 2.0 ± 0.2%; Tg
cultures: 14.0 ± 2.0%, p < 0.0001; 21 DIV, wt cultures: 3.0 ± 0.2%; Tg cultures: 24.0 ± 5.0%,
p < 0.0001 (wt vs Tg); p = 0.0003 (14 DIV vs 21 DIV). n = 50 cells from each condition. (C)
Representative images of a wild-type or Tg GFP labeled mature neurons (21 DIV). (D) Sholl
analysis of total number of branch point on basal dendrites of neuron from wild-type and Tg
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cultures shows decreased complexity in Tg neurons starting at 30 µm from the cell body. n =
25 cells from each condition. (E) Representative GFP labeled dendritic segments studded with
mature spines from wild-type and Tg neurons show a loss of spines on Tg dendrites that is
confirmed in quantitative assay of spine densities determined in neurons without apparent
dystrophies at 21 DIV in wild-type and Tg cultures (F). n = 4 culture/experiment and 400
spines from each condition. * P < 0.05; ** P < 0.01; Data represent mean ± SD.
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Aβ induces NFATc4 and CaN aberrant nuclear localization in Tg neurons in culture and AD
postmortem brains. (A) Immunostaining images of NFATc4 in Tg or wild-type neurons.
Neurons from Tg or wild-type culture at 14 DIV are labeled with NFATc4 (red), MAP2 (green)
and Hoechst nuclear counterstain (blue). Compared with wild-type neurons, Tg neurons show
higher immunoreactivity of NFATc4 in the nuclei. (B) Quantification of NFATc4 nuclear
immunoreactivity obtained from A. n = 40 cells from 3 different experiments, * P < 0.05; Data
represent mean ± SD. (C) Immunostaining images of CaN in Tg or wild-type neurons. Neurons
from Tg or wild-type culture at 14 DIV are labeled with CaN (green) and Hoechst nuclear
counterstain (blue). Compared with wild-type neurons, Tg neurons show higher
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immunoreactivity of CaN in the nuclei. (D) Quantification of CaN nuclear immunoreactivity
obtained from C. n = 40. * P < 0.01; Data represent mean ± SD. (E and F) Subcellular fractions
were prepared from brains of AD patients or controls and analyzed by immunoblotting for
NFATc4 and cytoplasmic or nuclear control proteins GAPDH, HDAC1, respectively. (G)
Semiquantification of NFATc4 immunoreactivity in E. NFATc4 was detected in all three
compartments, but substantially enriched in nuclei in AD brains (n = 6 for each condition). *
P < 0.05; Data represent mean ± SD. (H and I). Semiquantification of immunoreactivity from
each subcellular fraction for both full-length CaN (60 kDa) (H) and CaNCA (45 kDa) (I). Insert
in (I) shows representative blots of CaN in nuclear fraction. * P < 0.05; Data represent mean
± SEM.
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Conditioned medium induces NFATc4 - aberrant nuclear translocation in wild-type cultured
neurons. (A) Schematic representation of AKAP79 inhibitory peptide for CaN (A1) and AAV2
viral vectors (AAV-CMV/CBA-WPRE) with AKAP79 inhibitory peptide (A2). (B) Aβ
depletion or CaN inhibition with AKAP79 inhibitory peptide prevents Tg CM induced
NFATc4 activation as seen in cultures stained with NFATc4 (red), MAP2 (green) and Hoechst
nuclear counterstain (blue) from each experimental condition. (C) Quantification of NFATc4
- aberrant nuclear translocation induced by TgCM in wild-type cultured neurons. The ratio of
nucleus to cytosoplasm is shown. TgCM causes an increase in the nucleus/cytoplasm ratio of
NFATc4 that is dependent upon the presence of Aβ (since anti-Aβ antibody 3D6 prevents the
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effect). Inhibition of CaN activation by AKAP79 peptide also prevented the increase in the
nucleus/cytoplasm ration of NFATc4 (n > 40 cells). Data represent mean ± SD. *, P < 0.05.
D, Quantification of NFATc4 - aberrant nuclear translocation induced by different SEC-
fractions in wild-type cultured neurons. Application of SEC fractions 6–7 (sAPP fraction)
either from TgCM or wtCM caused no significant difference on the nucleus/cytoplasm ratio
of NFATc4. However, application of SEC fractions 18–19 (Aβ fraction) of TgCM onto wild-
type neurons for 24 hours caused significant increase in translocation of NFATc4 to the
nucleus, but no changes were observed in neurons applied with the same SEC fractions of
wtCM. Immunodepletion of Aβ from the fractions 18–19 of TgCM with 3D6 prevented the
increase in the nucleus/cytoplasm ratio of NFATc4. (n > 35 cells). Data represent mean ± SD.
*, P < 0.05.
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Aberrant neuronal morphologies induced by TgCM or APP overexpressing are prevented by
Aβ depletion. (A) Primary cultures were maintained in Tg CM for 21 DIV in different culture
conditions, as indicated. The percentage of neurons with dendritic dystrophies at 21 DIV is
increased in the presence of Tg CM, and this beading can be prevented by immunodepletion
of Aβ. (B and C) Representative GFP labeled mature neurons (B) and Sholl analysis of
branching on dendrites of neurons from indicated conditions shows that Tg CM reduced
branching and that this is rescued by immunodepletion of Aβ with 3D6 (C). (D) Spine densities
are determined in neurons without apparent dystrophies in each experimental condition,
showing a decrease in spine density with Tg CM that could be rescued with 3D6 treatment.
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(E, F, G and H) Aβ depletion prevents APP overexpression induced morphological
abnormalities. In Tg cultures at 21 DIV, dendritic dystrophies (E), dendritic attenuation (F and
G) and spine loss (H) are prevented by Aβ depletion with 3D6. 60 cells were analyzed per
experimental condition in each experiment. *, P < 0.05; ** P < 0.01; * in G, indicates p < 0.05
(Tg with 3D6 vs Tg with boiled 3D6). Data represent mean ± SD.
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CaN inhibition by AKAP79 inhibitory peptide prevents Tg CM induced morphological
abnormalities. Dendritic dystrophies (A), dendritic attenuation (B and C) and spine loss (D)
in wild-type cultured neurons growing in Tg CM are significantly prevented by CaN inhibitory
peptide AKAP79. * in C, indicates statistical significance (p < 0.05; TgCM with AKAP79 vs
TgCM with vector). Data are mean ± SD from three independent experiments in triplicate.
(E, F, G and H) CaN inhibition by AKAP79 inhibitory peptide prevents APP overexpression
induced morphological abnormalities. In Tg cultures at 21 DIV, dendritic dystrophies (E),
dendritic attenuation (F and G) and spine loss (H) are prevented by CaN inhibitory peptide
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AKAP79. * in G, indicates statistically significant (p < 0.05; Tg with AKAP79 vs Tg with
vector). Data are mean ± SD from three independent experiments, each in triplicate.
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Inhibition of CaN-NFAT interaction by VIVIT prevents Tg CM induced morphological
abnormalities. Dendritic dystrophies (A), dendritic attenuation (B and C) and spine loss (D)
in wild-type cultured neurons growing in Tg CM are significantly prevented by VIVIT
(CALBIOCHEM, Cat# 480401). * in C, indicates statistically significant (p < 0.05; TgCM
with VIVIT vs TgCM with DMSO). Data are mean ± SD from three independent experiments
in triplicate. (E, F, G and H) Inhibition of CaN-NFAT interaction by VIVIT prevents APP
overexpression induced morphological abnormalities. In Tg cultures at 21 DIV, dendritic
dystrophies (E), dendritic attenuation (F and G) and spine loss (H) are prevented by VIVIT. *
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in G, indicates statistically significant (p < 0.05; Tg with VIVIT vs Tg with DMSO). Data are
mean ± SD from three independent experiments in triplicate.
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Wild-type cultured neurons overexpressing a constitutively active CaN construct, CaNCA,
develop abnormal morphology which is a phenocopy of the Aβ effect. Overexpression of
CaNCA, but not CaNwt or vector control, into wild-type cultures induces dendritic dystrophies
(A and B; arrows indicated local swelling of dendrites), simplification of dendritic arboration
(C and D) and spine loss (E and F). Neurons expressing CaNCA displayed significantly more
neurons with dendritic dystrophies, simplified dendritic complexity and spine loss than either
CaNwt or vector expressing neurons. *, p < 0.05; * in D, indicates statistical significance (p <
0.05; CaNwt vs CaNCA). Data are mean ± SD from three independent experiments, each in
triplicate.
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Overexpression of CaNCA, but not CaNwt, in the intact mouse brain induces abnormal
morphologies. (A) Representative images in different magnifications from cortex (A1 and A3)
and hippocampal areas (A2 and A4) after CaNCA or CaNwt transduction showing GFP
expression in fixed postmortem brain sections stained with GFP antibody. (B) Representative
high power images of neuronal processes corresponding to areas indicated in A from CaNwt
(B1 and B3) or CaNCA (B2 and B4) injected mice. Arrows indicated neurites or axons with
typical dystrophies. (C–D) Images of dendritic spine (C) and quantitative analysis of spine
densities (D) from live imaging of neurons without apparent dystrophies shows a decrease in
spine density with CaNCA overexpression. In C, arrows indicated spines and arrow head
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indicated neurites with typical dystrophies. *, P < 0.05; Values represent mean ± SD (n = 4
animals for each condition and total > 400 spines).
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Abnormal morphologies are prevented by overexpression of CaN inhibitory peptide AKAP79
in APP/PS1 mouse brain. (A1) in vivo low magnification image of GFP expressing neurites
and axons (green), blood vessels containing Texas Red, and amyloid deposition stained with
methoxy-XO4 (blue). Arrows indicated Aβ deposits. (A2 and A3) High magnification live
images taken from around 100 µm below the brain surface in the neocortex of adult APP/PS1
mice show dendritic spines and dystrophies in both vector and AKAP79 expressing conditions.
(B–D) Quantification of spine density (B), dendritic dystrophies (C) and neurite curvature
(D) near Aβ deposits in vector or AKAP79 expressing APP/PS1 mouse brain shows that
AKAP79 expression decreases dystrophy size (B, vector: 16.4 ± 6.1 µm2; AKAP79, 12.8 ±
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3.6, p = 0.029, n = 45 from 4 animals), increases spine density (C, vector: 17.8 ± 3.0 / 100µm;
AKAP79, 28.3 ± 6.1, p < 0.001, n > 400 spines), and decreases abnormal neurite curvature
near plaques (D). (n = 4 animals for each condition and total > 400 spines). (E) Postmortem
sections indicated axonal dystrophies with SMI312 staining (red) and plaques with thioflavine
S (blue) shows that plaque-associated axonal dystrophies are reduced (quantified in f, vector:
16.4 ± 6.1 µm2; AKAP79, 12.8 ± 3.6, p = 0.0291, n = 45 plaques from 4 animals) in areas
injected with AKAP79. (F) Quantification of numbers of axonal dystrophies per single Aβ
deposits from postmortem sections. Values represent mean ± SD *, P < 0.05; ** P < 0.01;
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